HYDERABAD: Japan’s drug regulator, the Pharmaceuticals and Medical Devices Agency (PMDA), is set to open an India office soon, amid concerns over an aging population and burgeoning healthcare costs in a country dominated by branded drugs.
The move is expected to help Indian generic drug manufacturers, which have been seeking to increase their presence in Japan either through exports or by forging joint ventures with partners in that country. Japan’s market, the second-largest in the world after the US, is worth $110 billion.
READ
/////////Japan, drug regulator, PMDA , open office, India
DRUG REGULATORY AFFAIRS INTERNATIONAL 